Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MTMR9 |
| Upstream (Parents) |
|---|
| (<<) VCAM1 → MTMR9 |
| (<<) EML1 → MTMR9 |
| (<<) HEG1 → MTMR9 |
| (<<) ZNF45 → MTMR9 |
| Downstream (Children) |
|---|
| MTMR9 → LCK (>>) |
| MTMR9 → POPDC2 (>>) |
| MTMR9 → PSMD9 (>>) |
| MTMR9 → NODAL (>>) |
| MTMR9 → LAMA1 (>>) |
| MTMR9 → KLK3 (>>) |
| MTMR9 → RAP1GAP (>>) |
| MTMR9 → ACAN (>>) |
| MTMR9 → TSPAN32 (>>) |
| MTMR9 → RPL21P68 (>>) |
| MTMR9 → TMEM22 (>>) |
| MTMR9 → NRIP1 (>>) |
| MTMR9 → BMP1 (>>) |
| MTMR9 → ZNF45 (>>) |
| MTMR9 → FJX1 (>>) |
| MTMR9 → GJA3 (>>) |
| MTMR9 → RAX (>>) |
| MTMR9 → TTC23 (>>) |
| MTMR9 → KCTD7 (>>) |
